DiPietro Kenneth's Form 4 filing
Cerevel Therapeutics Holdings, Inc. (CERE) · filed Dec 27, 2023
- Accession no.
- 0000950170-23-073306
- Filed
- Dec 27, 2023
- Trade date
- Dec 22, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $331.6K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DiPietro KennethCIK 0001540188 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $3.50 | +$28,000 | 32,663 | Direct | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −8,000 | $41.45 | −$331,600 | 24,663 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 302,242 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.